Avidity Biosciences (NASDAQ: RNA)
La Jolla, CA
Developing a new class of drug candidates, antibody-siRNA conjugates (ARCsTM)
Website: www.aviditybiosciences.com/
AVROBIO (NASDAQ: AVRO)
Boston, MA
Developing lentiviral based gene therapies
Website: www.avrobio.com
Precision Biosciences (NASDAQ: DTIL)
Durham, NC
Developing ARCUS genome editing to target oncology and genetic disorders
Website: http://precisionbiosciences.com/
Zymeworks (NYSE: ZYME)
Vancouver, BC, Canada
Developing best in class protein therapeutics for cancer, autoimmune and inflammatory diseases
Website: www.zymeworks.com
Antiva Biosciences
San Francisco, CA
Developing novel, localized treatments for HPV associated diseases
Website: www.antivabio.com
F2G
Manchester, UK
Developing novel therapeutics for life threatening fungal diseases
Website: www.f2g.com
Gliknik
Baltimore, MD
Creating novel therapeutics for cancer and immune disorders
Website: www.gliknik.com
Navitor Pharmaceuticals
Cambridge, MA
Developing novel, first-in-class, selective mTORC1 modulators
Website: http://navitorpharma.com/
ReViral
London, England
Developing novel anti-viral drugs to treat RSV
Website: www.reviral.co.uk
Turnstone Biologics
New York, NY
Developing targeted viral immunotherapies to fight cancer
Website: http://turnstonebio.com/
Vero Biotech
Atlanta, GA
Developing the next generation of inhaled nitric oxide (NO) products
Website: www.vero-biotech.com